Common large partialVWFgene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population-Reference-Cited by-同舟云学术

Common large partialVWFgene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population

Published:2011-05 Issue:5 Volume:9 Page:945-952
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:

Author:

MOHL A.,BODA Z.,JAGER R.,LOSONCZY H.,MAROSI A.,MASSZI T.,NAGY E.,NEMES L.,OBSER T.,OYEN F.,RADVÁNYI G.,SCHLAMMADINGER Á.,SZÉLESSY ZS.,VÁRKONYI A.,VEZENDY K.,VILIMI B.,SCHNEPPENHEIM R.,BODÓ I.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2011.04250.x/fullpdf

Reference39 articles.

1. von Willebrand disease;Nichols;Medicine (Baltimore),1997

2. Clinical diagnosis of von Willebrand disease;Federici;Haemophilia,2004

3. Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis;Nichols;Proc Natl Acad Sci USA,1991

4. Molecular genetics of von Willebrand disease;Ginsburg;Thromb Haemost,1999

5. The molecular biology of von Willebrand disease;Keeney;Clin Lab Haematol,2001

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS;Journal of Thrombosis and Haemostasis;2023-04

2. Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS;Blood Advances;2021-08-05

3. Phage display broadly identifies inhibitor‐reactive regions in von Willebrand factor;Journal of Thrombosis and Haemostasis;2021-07-28

4. Phage Display Broadly Identifies Inhibitor-reactive Regions in von Willebrand Factor;2021-03-09

5. The Current Understanding of Molecular Pathogenesis of Quantitative von Willebrand Disease, Types 1 and 3;Hämostaseologie;2020-01-22